EA201791038A1 - Лечение непереносимости энтерального питания - Google Patents
Лечение непереносимости энтерального питанияInfo
- Publication number
- EA201791038A1 EA201791038A1 EA201791038A EA201791038A EA201791038A1 EA 201791038 A1 EA201791038 A1 EA 201791038A1 EA 201791038 A EA201791038 A EA 201791038A EA 201791038 A EA201791038 A EA 201791038A EA 201791038 A1 EA201791038 A1 EA 201791038A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- inputability
- treatment
- enteral food
- enteral
- food
- Prior art date
Links
- 230000035764 nutrition Effects 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Abstract
Непереносимость энтерального питания (EFI) может эффективно лечиться посредством введения терапевтически эффективных доз улиморелина каждые 8 ч (три раза в день). Терапевтическое воздействие может быть получено от однократного и последовательного ежедневного дозирования, включая периоды до недели или больше.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462078888P | 2014-11-12 | 2014-11-12 | |
PCT/US2015/060222 WO2016077498A1 (en) | 2014-11-12 | 2015-11-11 | Treatment of enteral feeding intolerance |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201791038A1 true EA201791038A1 (ru) | 2017-11-30 |
Family
ID=55955006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201791038A EA201791038A1 (ru) | 2014-11-12 | 2015-11-11 | Лечение непереносимости энтерального питания |
Country Status (12)
Country | Link |
---|---|
US (1) | US10092621B2 (ru) |
EP (1) | EP3217996A4 (ru) |
JP (1) | JP2017533951A (ru) |
KR (1) | KR20170085539A (ru) |
CN (1) | CN107106636A (ru) |
AU (1) | AU2015346323A1 (ru) |
CA (1) | CA2967355A1 (ru) |
EA (1) | EA201791038A1 (ru) |
IL (1) | IL252234A0 (ru) |
MX (1) | MX2017006205A (ru) |
SG (1) | SG11201703884PA (ru) |
WO (1) | WO2016077498A1 (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10092621B2 (en) | 2014-11-12 | 2018-10-09 | Lyric Pharmaceuticals Inc. | Treatment of enteral feeding intolerance |
WO2017197131A1 (en) * | 2016-05-11 | 2017-11-16 | Lyric Pharmaceuticals Inc. | Treatment of enteral feeding intolerance and muscle wasting |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU682894B2 (en) * | 1993-10-28 | 1997-10-23 | Institut National De La Recherche Agronomique | Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man |
US20090259279A1 (en) | 2002-03-22 | 2009-10-15 | Dobak Iii John D | Splanchnic nerve stimulation for treatment of obesity |
US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
US7491695B2 (en) | 2003-06-18 | 2009-02-17 | Tranzyme Pharma Inc. | Methods of using macrocyclic modulators of the ghrelin receptor |
WO2007113202A1 (en) | 2006-03-31 | 2007-10-11 | Glaxo Group Limited | Piperazine derivatives as growth hormone secretagogue (ghs) receptor agonists |
US8828953B2 (en) | 2009-04-20 | 2014-09-09 | NaZura BioHealth, Inc. | Chemosensory receptor ligand-based therapies |
CA2775925A1 (en) | 2009-09-30 | 2011-04-07 | Tranzyme Pharma, Inc. | Salts, solvates and pharmaceutical compositions of macrocyclic ghrelin receptor agonists and methods of using the same |
AU2010313282A1 (en) | 2009-10-30 | 2012-05-24 | Ocera Therapeutics, Inc. | Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
US20130261011A1 (en) | 2012-03-30 | 2013-10-03 | Tufts Medical Center, Inc. | Analyzing neonatal saliva and readiness to feed |
US20130316002A1 (en) | 2012-05-22 | 2013-11-28 | Depomed, Inc. | Compositions and methods for treating gastrointestinal motility dysfunction |
CN104470524A (zh) | 2012-05-25 | 2015-03-25 | 拉夸里亚创药株式会社 | 用于治疗胃酸缺乏症的生长激素释放肽受体激动剂 |
CN110354265A (zh) | 2012-10-24 | 2019-10-22 | 第一三共株式会社 | 用于肌萎缩性侧索硬化的治疗剂 |
US10092621B2 (en) | 2014-11-12 | 2018-10-09 | Lyric Pharmaceuticals Inc. | Treatment of enteral feeding intolerance |
WO2017083882A1 (en) | 2015-11-11 | 2017-05-18 | Lyric Pharmaceuticals Inc. | Treatment of enteral feeding intolerance and other conditions using ulimorelin analogs |
WO2017097328A1 (en) | 2015-12-07 | 2017-06-15 | Arcelik Anonim Sirketi | Divider assembly for use in the vegetable drawer of a refrigerator |
WO2017197131A1 (en) | 2016-05-11 | 2017-11-16 | Lyric Pharmaceuticals Inc. | Treatment of enteral feeding intolerance and muscle wasting |
WO2017197328A1 (en) | 2016-05-12 | 2017-11-16 | Lyric Pharmaceuticals Inc. | Treatment of enteral feeding intolerance and muscle wasting with relamorelin |
-
2015
- 2015-11-11 US US15/526,262 patent/US10092621B2/en not_active Expired - Fee Related
- 2015-11-11 SG SG11201703884PA patent/SG11201703884PA/en unknown
- 2015-11-11 AU AU2015346323A patent/AU2015346323A1/en not_active Abandoned
- 2015-11-11 WO PCT/US2015/060222 patent/WO2016077498A1/en active Application Filing
- 2015-11-11 MX MX2017006205A patent/MX2017006205A/es unknown
- 2015-11-11 EA EA201791038A patent/EA201791038A1/ru unknown
- 2015-11-11 CN CN201580073216.3A patent/CN107106636A/zh active Pending
- 2015-11-11 EP EP15858484.7A patent/EP3217996A4/en not_active Withdrawn
- 2015-11-11 KR KR1020177015829A patent/KR20170085539A/ko unknown
- 2015-11-11 CA CA2967355A patent/CA2967355A1/en not_active Abandoned
- 2015-11-11 JP JP2017526590A patent/JP2017533951A/ja active Pending
-
2017
- 2017-05-11 IL IL252234A patent/IL252234A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3217996A4 (en) | 2018-06-20 |
EP3217996A1 (en) | 2017-09-20 |
US20170304395A1 (en) | 2017-10-26 |
MX2017006205A (es) | 2017-11-17 |
KR20170085539A (ko) | 2017-07-24 |
AU2015346323A1 (en) | 2017-06-22 |
CA2967355A1 (en) | 2016-05-19 |
SG11201703884PA (en) | 2017-06-29 |
IL252234A0 (en) | 2017-07-31 |
WO2016077498A1 (en) | 2016-05-19 |
JP2017533951A (ja) | 2017-11-16 |
CN107106636A (zh) | 2017-08-29 |
US10092621B2 (en) | 2018-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201790932A1 (ru) | Дозировка и введение нефукозилированных анти-cd40 антител | |
PH12016501790A1 (en) | Pharmaceutical compositions of therapeutically active compounds | |
EA201592106A3 (ru) | Локальное сопутствующее введение толерогенных синтетических наноносителей для снижения гиперчувствительности типа i и гиперчувствительности типа iv | |
EA201991484A1 (ru) | Лекарственные формы энзалутамида | |
PH12016501788B1 (en) | Pharmaceutical compositions of therapeutically active compounds | |
EA201691155A1 (ru) | Комбинации ингибиторов гистондеацетилазы и иммуномодулирующих лекарственных средств | |
EA201391616A1 (ru) | Применение тиазолидных соединений для предотвращения и лечения вирусных заболеваний, рака и заболеваний, вызванных внутриклеточными инфекциями | |
EA201590703A1 (ru) | Ингибиторы mek при лечении вирусных заболеваний | |
EA201691481A1 (ru) | ИНГИБИТОРЫ C5a ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ПНЕВМОНИИ | |
MX2017004618A (es) | Inhibidores de la biosintesis de sulfato de heparano para el tratamiento de enfermedades. | |
EA201692313A1 (ru) | Производные индолизина в качестве ингибиторов фосфоинозитид-3-киназ | |
EA201790442A1 (ru) | Трициклические азотсодержащие соединения для лечения инфекции, вызываемой neisseria gonorrhoeae | |
EA201691918A1 (ru) | Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения | |
EA201690039A1 (ru) | Ингибиторы rorc2 и способы их применения | |
EA201491500A1 (ru) | Способы лечения фиброза | |
EA201791038A1 (ru) | Лечение непереносимости энтерального питания | |
EA202091112A1 (ru) | Сокристаллы, фармацевтические композиции на их основе и способы лечения, предусматривающие их применение | |
MX2016006544A (es) | Witanolidos utiles para el tratamiento de enfermedades neurodegenerativas. | |
EA202190626A3 (ru) | Комбинация тразодона и габапентина для лечения боли | |
RU2014107146A (ru) | Способ профилактики канцерогенного действия диэтилнитрозамина у экспериментальных животных | |
EA201992762A1 (ru) | Трансмукозальные устройства для доставки лекарств для применения при облегчении хронической боли | |
EA201891647A1 (ru) | Фармацевтическая композиция для профилактики и лечения нарушений сна | |
UA114464U (xx) | Спосіб лікування атеросклерозу | |
RU2014117221A (ru) | Способ моделирования хронической токсической артериальной гипертонии и кардиопатии | |
UA95037U (uk) | Спосіб лікування неалкогольного стеатогепатиту |